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ABSTRACT
The mechanism by which type-2A topoisomerases
transport one DNA duplex through a transient
double-strand break produced in another exhibits
fascinating traits. One of them is the fine coupling
between inter-domainal movements and ATP usage;
another is their preference to transport DNA in par-
ticular directions. These capabilities have been
inferred from in vitro studies but we ignore their sig-
nificance inside the cell, where DNA configurations
markedly differ from those of DNA in free solution.
The eukaryotic type-2A enzyme, topoisomerase II, is
the second most abundant chromatin protein after
histones and its biological roles include the decate-
nation of newly replicated DNA and the relaxation of
polymerase-driven supercoils. Yet, topoisomerase II
is also implicated in other cellular processes
such as chromatin folding and gene expression, in
which the topological transformations catalysed
by the enzyme are uncertain. Here, some capabil-
ities of topoisomerase II that might be relevant
to infer the enzyme performance in the context
of chromatin architecture are discussed. Some
aspects addressed are the importance of the DNA
rejoining step to ensure genome stability, the regu-
lation of the enzyme activity and of its putative
structural role, and the selectively of DNA transport
in the chromatin milieu.
INTRODUCTION
Biochemical and structural studies conducted in the past
two decades have established the general mechanism by
which type-2A topoisomerases transport, in an ATP-
dependent manner, one DNA duplex through a transient
double-strand break produced in another (1–4). All the
enzymes of this class (Bacterial DNA Gyrase, bacterial
topoisomerase IV and eukaryotic topoisomerase II) are
functional dimers of three structural domains: an ATP-
ase or N-terminal domain, and the B0 and A0 domains
that constitute the DNA cleavage-rejoining core (3).
Before interacting with DNA, type-2A topoisomerases
have the shape of an open clamp, in which the N-terminal
domains are located at the tips and the A0 domains dimer-
ize at the hinge (5,6). The DNA double helix to be gated
(named G-segment) ﬁrst enters the open clamp and
binds to the cleavage-rejoining core (7). Binding of ATP
causes the N-terminal domains to interact and the clamp
closes. If this closure leads to the capture of a second
DNA double helix inside the clamp, a cascade of confor-
mational changes ensues (8). The captured DNA (named
T-segment) is transported through a gate transiently
opened in the bound G-segment. For this process, the
G-segment is cleaved by two trans-estheriﬁcation reactions
that let the 50 ends of the severed strands covalently linked
with a pair of tyrosine residues, one in each half of
the topoisomerase (9,10). After crossing the G-segment,
the T-segment reaches the cavity delimited by the A0
domains and it is then expelled from the topoisomerase
through the side opposite the one it entered, by the A0–A0
dimer interface at the hinge of the closed clamp (8,11).
ATP hydrolysis begins during T-segment transport and
release of the hydrolytic products allows the N-terminal
domains to come apart leaving the enzyme ready for a new
reaction cycle.
The DNA transport mechanism of type-2A topoisom-
erases displays some fascinating traits. One of them is the
ﬁne coupling between inter-domainal movements and
ATP usage during DNA transport (1,4). The translocation
of the T-segment through the complete dimer interface
of type-2 topoisomerases demands energetically well-
balanced and robust conformational states during the crit-
ical DNA cleavage, DNA gating and DNA rejoining
steps. Backtracking of the T-segment would cause unnec-
essary breakages of the G-segment and no net DNA
transport. Dissociation of the enzyme halves linked
to cleaved DNA would cause chromosomal breaks
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type-2A topoisomerases are the DNA transport prefer-
ences that distinguish some enzymes. On the one side,
DNA gyrase is specialized to carry out intra-molecular
transport. After binding the G-segment, the gyrase–
DNA complex enforces the juxtaposition of a contiguous
T-segment such that it conﬁgures a positive DNA crossing
(12,13). As long as this conﬁguration can be settled, DNA
gyrase removes positive supercoils and introduce negative
ones into circular DNA (14). On the other side, bacterial
topoisomerase IV and eukaryotic topoisomerase II can
carry out both intra- and inter-molecular DNA transport.
Consequently, they can catenate–decatenate, knot–unknot
and remove supercoils. These enzymes, however, cannot
supercoil DNA alike gyrase. Instead, topoisomerase IV
and topoisomerase II reduce the topological complexity
of DNA (catenation, knotting and supercoiling) below
the levels expected at thermal equilibrium (15). How
these enzymes achieve DNA topology simpliﬁcation is
unclear. Several models have been proposed to explain
how they assess the global topology of a DNA molecule
by their local interactions with DNA segments (16,17).
In parallel to biochemical and structural studies on
type-2A topoisomerases, the biological functions of this
abundant and essential class of enzymes had also been
the focus of attention for long time (18). In eubacteria,
DNA gyrase and topoisomerase IV complete diﬀerent
tasks according to their distinct DNA transport prefer-
ences. In most eukaryotes, however, a single form of
topoisomerase II appears to carry out diverse biological
roles (18,19). The major known and essential function of
the enzyme is the decatenation of replicated DNA
duplexes after the S phase. When two replication forks
converge, the last unreplicated segment becomes too
short to be unlinked by topoisomerase I or II. The residual
intertwines between the parental DNA are then converted
to catenane links between the newly replicated daughter
duplexes. Removal of such catenanes by topoisomerase II
is essential for proper chromosome segregation (recent
studies on this topic are refs. 20–22). Another major
known cellular activity of topoisomerase II is the relax-
ation of positive supercoils generated ahead of the repli-
cation forks, as well as of oppositely supercoiled domains
generated during DNA transcription (23,24). Although
eukaryotic topoisomerase I can also fulﬁl this function,
topoisomerase II is likely to be the main relaxase of
DNA supercoils inside the cell (25).
In addition to decatenating replicated DNA and relax-
ing polymerase-driven supercoils, eukaryotic topoisom-
erase II has been implicated in many other chromosomal
processes. A common trait in all these processes is that
the topological transformation (if any) catalysed by the
enzyme is uncertain. For instance, topoisomerase II is
well known to be involved in chromosome condensation,
but its precise role in the many steps for assembling mor-
phologically distinct interphase chromosomes and highly
condensed metaphase chromosomes remain unclear. At
each of these steps, whether a continual DNA transport
activity of topoisomerase II is required for chromatin con-
densation-decondensation or whether the enzyme mainly
has a structural role are still controversial questions (26).
Other examples of unknown topology conversion are the
implications of topoisomerase II in the local regulation
of chromatin architecture and in gene expression. Such
biological roles became evident after discovering that
mammals harbour two topoisomerase II isozymes, IIa
and IIb (27). Both isozymes carry out similar strand-
passing activities in vitro (28), though IIa is found to
relax positively supercoiled plasmids faster than negatively
supercoiled ones (29). Both isozymes are diﬀerentially
regulated during cell growth and can not compensate for
each other in vivo (30–32). On one hand, IIa is only found
in proliferating cells, with an expression peak at late S and
G2/M phases of the cell cycle (33,34), and it is most likely
involved in DNA replication, chromosome condensation–
decondensation and sister chromatid segregation (35–37).
These functions are quite analogous to those known for
the single topoisomerase II form found in budding yeast,
ﬁssion yeast and drosophila (38–41). On the other hand,
IIb is found in all mammalian cell types but with promi-
nent expression in terminally diﬀerentiated cells (42–47).
The biological function of topoisomerase IIb is intriguing.
Recent studies uncovered a role in activation–repression
of developmentally regulated genes at late stages of diﬀer-
entiation. The enzyme binds to the 50 region of a number
of such IIb-sensitive genes (48). Topoisomerase IIb has
been also found catalysing a site-speciﬁc transient
double-stranded DNA break in some gene promoters,
which lead to local changes of chromatin architecture
and activation of transcription (49). These ﬁndings suggest
that topoisomerase IIb, and perhaps the single topoisom-
erase II form found in yeasts and drosophila, produce
critical structural changes in localized chromatin regions
to regulate genome transactions.
To ﬁnd out the range of DNA manipulations that
topoisomerase II might catalyse in vivo, it is essential to
sum up the capabilities of the enzyme inferred from
in vitro studies. Some topoisomerase II activities learned
with DNA in free solution that might be relevant for the
performance of the enzyme in the context of chromatin
architecture and dynamics are surveyed below.
A double-lock rule toopen DNA gates and, aboveall,
to close them
Most studies on topoisomerase II mechanism had
focussed on the DNA cleavage and gating steps, the
DNA transport preferences, and the coupling of inter-
domainal movements to ATP usage. However, a less-
attended but critical aspect of the enzyme operation that
needs to be absolutely eﬀective is the rejoining of the gated
DNA. Intracellular DNA is gated by topoisomerase II
many million times per cell cycle. Consider, for example,
yeast cells deﬁcient in topoisomerase I, in which topo-
isomerase II alone relaxes the supercoils raised during
DNA transcription and reduces to zero the linkage
between complementary DNA strands during their repli-
cation. Any single DNA gating event not followed by the
proper rejoining step will put at risk genome integrity and
cell survival. It is reasonable to assume then that most
mechanic traits of the enzyme are tuned to ensure rejoin-
ing rather than DNA cleavage and DNA transport.
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rejoining step readily produce cell death and have, there-
fore, prominent pharmacological interest.
But apart from biochemical targeting, many physiolog-
ical processes might also threaten the DNA rejoining step.
For instance, in contrast to DNA in free solution, intra-
cellular DNA is subjected to considerable twisting, bend-
ing and pulling forces generated by DNA tracking
ensembles and the conformational dynamics of chromatin
ﬁbers. In this environment, holding both severed ends of
the gated DNA is essential. Yet, the mechanism of the
type-2 topoisomerases implies that none of its dimer
interfaces is a permanent interaction. The path of the
T-segment involves the sequential crossing of the entrance
or N-gate, the DNA gate and the exit or C-gate.
Coordination among these three gates is therefore critical
to preclude the risk of the two halves of the enzyme
coming apart while gating the DNA. In that regard,
biochemical studies with yeast topoisomerase II indicate
that gate opening and closure follow a double-lock rule: a
given gate can open only if the other two are closed (50).
Although the N-gate domain is not required for
G-segment cleavage, the DNA gate per se is not able to
widen unless ATP binds and closes the N-gate (50). Since
a captured T-segment cannot be held in the inter-domainal
region between the N-gate and the DNA gate, closure of
the N-gate and consequent capture of a T-segment is
likely to enforce the opening of the DNA gate (50).
Once a T-segment has reached the central cavity of the
enzyme and before the C-gate opens, the gated G-segment
DNA can be rejoined (11,50). Hence, opening of the
C-gate is likely to be triggered by the entrapment of the
T-segment after being squeezed by the sequential closure
of the N-gate and the DNA gate. These inter-domainal
couplings maximize the dimer stability, ensure a very tran-
sient DNA gating state and enforce unidirectional DNA
transport by precluding the backtracking of the T-segment
(Figure 1A).
The quaternary couplings during DNA transport in
topoisomerase II must be alike in topoisomerase IV and
DNA gyrase. However, they might diﬀer from those in
the less-extensively studied type-2B topoisomerases
Figure 1. Mechanical couplings for gate opening and closure in type-2 topoisomerases. (A) In type-2A enzymes (bacterial gyrase, topoisomerase IV,
topoisomerase II), the N-gate, DNA gate and C-gate appear to be mechanically coupled with a double-lock rule, such that a given gate can open
only if the other two are closed. This coordination minimizes the risk of the two enzyme halves from coming apart while gating the DNA. (a) When
the entrance N-gate is open, DNA might be cleaved but the DNA gate is not able to widen. (b) Upon ATP binding and closure of the N-gate, a
captured T-segment cannot be held in the inter-domainal region between the N-gate and DNA gate. The T-segment quickly crosses the DNA-gate
and reaches the central cavity of the enzyme. (c) The gated DNA is then rejoined. (d) The consequent entrapment of the T-segment enforces its exit
by a transient opening of the C-gate. (B) In type-2B enzymes (topoisomerase VI) there is no C-gate. Dimer stability depends on the coordination
between the N-gate and DNA gate. (a) When the entrance N-gate is open (no ATP bound) the DNA gate is locked. (b) Upon ATP binding and
closure of the N-gate, a captured T-segment is held in the central cavity of the enzyme prior to the aperture of the DNA gate. (c) The captured
T-segment crosses then the DNA-gate and exits the complex.
Nucleic AcidsResearch, 2009, Vol.37,No. 3 723(Archea topoisomerase VI and plant topoisomerase VI)
(51,52). These enzymes share several mechanistic features
with the type-2A topoisomerases, but there are signiﬁcant
structural diﬀerences between the two families (53). For
T-segment capture, the ATPase domains of type-2B dimer-
ize upon ATP binding alike the N-gate in type-2A enzymes
(54). The DNA cleavage-rejoining core of type-2B also
contains counterparts of the structural motifs of the
DNA-gate of the type-2A enzymes. However, type-2B
enzymes do not have an exit- or C-gate (55). The trans-
ported duplex is outside the complex right after crossing
the DNA gate (Figure 1B). Therefore, dimer stability
during the DNA gating step relies mostly in the closure
of the N-gate. Type-2A and type-2B topoisomerases
should have then distintc couplings between their ATPase
and DNA cleavage-rejoining modules. Remarkably, con-
trary to type-2A topoisomerases (50), the ATPase domains
of type-2B enzymes are required for DNA cleavage (56)
and the cavity between the two gates of these enzymes
can accommodate a captured T-segment before widening
the DNA gate (55). The absence of a C-gate in type-2B
topoisomerases facilitates perhaps the dissociation of the
enzyme halves for some biological tasks. For instance,
reduced dimer stability could be operational in Spo11, a
type-2B related enzyme that mediates DNA double-strand
breaks during recombination (51,57).
Aside of ensuring dimer stability during the DNA cleav-
age and gating steps, another way to guarantee genome
integrity is to not cleave the DNA in the ﬁrst place. It is
conceivable that topoisomerase II discerns whether or
not a duplex is suitable for successful rejoining before
gating it. For example, if DNA is undergoing extreme
tension, its conformation might not be appropriate for
catalytic cleavage. In that regard, the recently solved crys-
tal structure of the cleavage-rejoining core of yeast topo-
isomerase II bound to DNA, reveals a complex producing
a 1508 DNA bend in the G-segment (58). A sharp bending
of the bound G-segment had previously been inferred
for bacterial topoisomerase IV and it is postulated to con-
tribute to the capacity of type-2A topoisomerases to sim-
plify DNA equilibrium conﬁgurations (59). Bending of
the G-segment might be a prerequisite for DNA cleavage,
thus protein conformational changes that accompany this
deformation create a bipartite catalytic site, in which each
DNA strand gets close to a reactive tyrosine and a coor-
dinated magnesium ion (58). Another possible function of
such DNA bending is that it would prevent topoisomerase
II from gating the duplex in regions undergoing severe
stretching forces (Figure 2A).
Recently, oligonucleotides with a pair of ﬂuorophores
straddling the DNA cleavage site have been used to
observe the dynamics of the DNA gate by FRET (60).
The experiment revealed that during steady-state ATP
hydrolysis ﬂuorophores repeatedly move over a distance
of 20A ˚ with comparable back and forth rate constants.
Whether these displacements reﬂected opening and closing
cycles of the DNA-gate is puzzling in two regards. First,
the putative open and closed states are nearly equally
probable in a steady state population, whereas all
previous biochemical data indicate that in this condition
only a small fraction of complexes is in the open
DNA-gate state. Second, as mentioned above, the capture
of a T-segment is likely required to enforce the opening of
the DNA gate. In the FRET experiment, however, no free
DNA was available to provide a T-segment. Thus, the
observed displacements could reﬂect mostly bending or
twisting distortions of the G-segment coupled to ATP
binding and hydrolysis but with no signiﬁcant widening
of the DNA gate. Such active deformation of DNA could
operate as a checkpoint to unlock the DNA-gate, as well
as a stock of elastic energy to deliver at the rejoining step.
By these means, topoisomerase II could discern whether
a duplex is suitable for proper rejoining before gating
it (Figure 2B).
Gate padlocks to fastenDNA andturn-off
topoisomerase activity
Identiﬁcation of topoisomerase II as one of the main com-
ponents of the nuclear matrix and metaphase chromosome
scaﬀold (61–63), as well as its preferential interaction to
SAR and MAR sequences (64–66), had lead to the pro-
posal of an structural role for the enzyme. The possibility
that topoisomerase II could be anchoraging DNA chro-
mosomal loops ﬁt well with the enzyme capabilities
to hold DNA through covalent bonds and to interact
simultaneously with several DNA segments (67,68). This
putative structural role was further supported by the dis-
covery of that, upon binding of a non-hydrolysable ATP
analogue, the topoisomerase constituted in vitro a high-
salt resistant complex with circular DNA molecules
(7,69,70). This observation was essential for unravelling
the mechanism of type-2 topoisomerases, reﬂecting the
Figure 2. Topoisomerase II might discern whether or not a DNA
domain is suitable for successful rejoining by bending the G-segment
before the gating step. (a) Proper bending of the interacting duplex will
be possible as long as the stretching tension along the DNA does not
exceed a threshold value ( o). This threshold is determined by the
tension ( p) that the enzyme is able to counteract to close the DNA
gate. (b) The active deformation of DNA, coupled to ATP binding
and hydrolysis, could operate then as a checkpoint to unlock the
DNA-gate, as well as a gain of elastic energy to be delivered in the
rejoining step.
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the protein ring detaching from a bound G-segment in the
absence of a DNA free-end. The topoisomerase–DNA
complex was resistant to salt concentrations up to 5M
NaCl or CsCl during several hours (71). Therefore, such
a topological interaction was an attractive mechanism to
fasten large chromosomal DNA loops, and it seemed
more convenient than holding the duplex with covalent
links that implied a permanent cleavage of DNA.
In the last decade, however, support for the proposed
structural role of topoisomerase II had faded since some
observations disputed the requirement of the enzyme to
maintain the shape of mitotic chromosomes. Although
topoisomerase II is required for mitotic chromosome
assembly in vitro, the enzyme could be extracted from
in vitro condensed chromosomes with no signiﬁcant
changes in the chromosome conformation (72). Other
in vivo studies, which used ﬂuorescently tagged human
DNA topoisomerases IIa and IIb, indicated that neither
enzyme is an immobile structural component of the chro-
mosomes (73). Moreover, several studies reported signiﬁ-
cant mitotic chromosome condensation even after genetic
knockdown or knockout of topoisomerase II (30,74–76).
Yet, other demonstrations indicated that topoisomerase II
remains stably bound in chromosomes assembled in vitro
after a round of DNA replication (77). More recent anal-
yses in several species including mammals, chicken,
C. elegans and Drosophila, came to agree in that topo-
isomerase II is not required for initial chromatin compac-
tion and formation of a longitudinal chromosome axis,
but that an axial distribution of the enzyme in late
prophase to metaphase is real, being dependent on the
presence of condensins (76,78,79). On the other side, the
existence of a rigid chromosome scaﬀold, in which
DNA loops could be anchored, is also no longer sustained
after some morphological and biophysical observations.
For instance, depletion of histone H1 results in longer
and thinner compacted mitotic chromosomes, and so
arguing against a stiﬀ scaﬀolding structure driving
chromosome condensation (80). Also, the elastic response
of native metaphase chromosomes and its alteration by
endonucleases rule out a contiguous internal non-DNA
(e.g. protein) scaﬀold. The elastic behaviour of mitotic
chromosomes suggests instead that they are shaped by
isolated DNA-crosslinking elements spaced by few kilo
base pairs (81,82).
From the above, the possibility that a highly stable
topoisomerase II–DNA complex plays a structural role
in chromosome architecture cannot be excluded. The clo-
sure of the enzyme around DNA is driven by ATP binding
and this conformation could be easily stabilized by some
cellular factor. Such factor could interact across the closed
N-gate domains, thus behaving like a molecular padlock.
Essentially, this is the case with bisdioxopiperazines, such
as ICRF-193, that bind to the interface of the dimerized
ATP-ase domains of topoisomerase II and preclude
N-gate reopening (83,84). The hypothetic existence of
gate padlocks could be also considered for the C-gate of
topoisomerase II. In this case, stabilisation of the exit gate
would be analogous to locking it by means of engineered
disulﬁde bonds (11,50). In such a case, a T-segment would
be captured, transported across the gated G-segment and
end up entrapped in the central chamber of the topoisome-
rase between the rejoined DNA-gate and the locked exit-
gate. If padlocks close both the C-gate and the N-gate
simultaneously, the topoisomerase would become a tight
toroidal structure, inside which two DNA segments could
be entrapped. This extreme can be observed in vitro by
closing the N-gate with a non-hydrolysable ATP analogue
in the yeast topoisomerase II mutant having the C-gate
locked by disulﬁde bonds (50). In this condition, the
enzyme would ﬁrmly hold DNA crossings (Figure 3).
In addition to stabilize topoisomerase II–DNA com-
plexes for structural purposes, another plausible function
of gate padlocks could be the regulation of the enzyme
activity, a subject that remains poorly understood.
Topoisomerase II can be phosphorylated in vitro on mul-
tiple serine and threonine residues, the majority of which
are located in its non-conserved C-terminal region. The
plausible eﬀects of phosphorylation in vivo remain contro-
versial, since most studies report that these modiﬁcations
do not produce signiﬁcant changes in the DNA transport
activity of the enzyme in vitro (85). Topoisomerase II can
also undergo poly(ADP-ribosyl)ation in vitro. Whether
this modiﬁcation occurs in vivo and has physiological sig-
niﬁcance is unclear (86). It is suggested that poly(ADP-
ribosyl)ation may play a role in the cellular distribution
and degradation the enzyme (87). More recently, topo-
isomerase II has been shown to undergo SUMO-lation
during mitosis (88–90). This modiﬁcation seems to be a
signal for targeting the enzyme to pericentromeric regions
of mitotic chromosomes and promotes the decatenation of
sister chromatids at anaphase (88–90). The question then
is what might prevent intracellular topoisomerase II to
hydrolyse ATP, to cleave DNA or to transport DNA
Figure 3. Gate padlocks can regulate topoisomerase activity and clamp
interacting DNA. Analogously to bisdioxopiperazines, such as ICRF-
193 that inhibit topoisomerase II activity, closure of the N-gate of
topoisomerase II upon ATP binding can be stabilized also by some
cellular factor. (A) Such gate padlocks could operate as inhibitors of
enzyme binding to chromosomal DNA. (B) If DNA is already bound
to the topoisomerase, an N-gate padlock would produce a high salt
resistant complex, which might serve to regulate the enzyme activity or
operate as a structural element for DNA organization. (C) Padlocks for
the C-gate could also exist. If both the N-gate and the C-gate were
stabilized in the closed conformation, the topoisomerase could clamp
two DNA duplexes, the G-segment and passed T-segment.
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tive way to turn-oﬀ these enzyme activities. As observed
with the topoisomerase inhibitor ICRF-193, locking of the
N-gate upon ATP binding can occur in the absence of
DNA (83). In this closed conformation, ATP hydrolysis
and inter-domainal movements are inhibited (Figure 3).
Gate padlocks could therefore be used to transport and
stock topoisomerase II inside the cell and let it operate
only where needed. So far, no gate padlock has been
found in cell extracts or described among the several pro-
teins that might physically interact with topoisomerase II.
One reason could be that they do not exist. Another
reason, however, is that proper assays to ﬁnd them have
not been conducted.
DNA transport selectivity in thechromatin milieu
Once topoisomerase II is bound to a G-segment, DNA
transport depends solely on the probability of ﬁnding a
potential T-segment properly positioned in the vicinity of
the N-gate of the enzyme (91). For naked DNA molecules
in free solution, such juxtaposition probability will be
determined by the global conﬁguration of the duplex,
and also by constrains that the topoisomerase might pro-
duce by its local interactions with DNA. This last aspect
should account for the enzyme capacity to drive DNA
topology below thermal equilibrium conﬁgurations and
for its chiral preferences (92,93). The question now is
whether our current understanding of juxtaposition prob-
ability of DNA segments on topoisomerase II, as inferred
from in vitro studies, is applicable to intracellular DNA.
Although the topological problems inside the cell are
equivalent to those portrayed in vitro, the conformational
dynamics of DNA is determined by a complex set of vari-
ables involving multiple molecular interactions, in addi-
tion to the topology of the duplex. For example,
although in living yeast cells both DNA topoisomerases
I and II are capable to relax plasmid minichromosomes
(94), in vitro studies revealed that topoisomerase II relaxes
nucleosomal DNA much faster than topoisomerase I (25).
Apparently, the DNA cross-inversion mechanism of
topoisomerase II is facilitated in nucleosome ﬁbres that
might favour the juxtaposition of DNA segments, whereas
the DNA strand-rotation mechanism of topoisomerase I
might be stalled by twist diﬀusion barriers imposed by
nucleosome organization. How chromatin aﬀects DNA
segment juxtaposition and the consequent topoisomerase
II activity is complex to envisage. On one hand, juxtapo-
sition can be favoured as DNA is intensely and extensively
more folded than in free solution. On the other hand, the
number of DNA segments suitable for topoisomerase II
manipulation is more reduced since many proteins
cover most of the DNA length. To further dissect this
problem, three types of DNA juxtaposition should be con-
sidered to occur in the intracellular landscape, each one
producing a diﬀerent outcome upon DNA transport by
topoisomerase II.
The ﬁrst type of DNA juxtaposition is that driven by
the topology conﬁguration. This is the case of the pre-
catenanes and catenane links generated between newly
replicated duplexes and the supercoils generated ahead
and behind DNA tracking ensembles. These structural
complexities are fully removed by topoisomerase II
in vivo. One question here is whether such juxtapositions
are conﬁgured inside the cell in the same way as in naked
DNA in vitro, and how such conﬁgurations might enhance
the DNA transport eﬃciency of topoisomerase II. For
instance, DNA decatenation by yeast topoisomerase II is
greatly enhanced by DNA supercoiling in vitro, being cate-
nane links removed much faster than coexisting supercoil
crossings (91). Moreover, DNA decatenation is more
eﬃcient in negative than in positively supercoiled circles
(93). These preferences, however, might not apply to intra-
cellular DNA unless newly replicated duplexes were
supercoiled. DNA conﬁgurations behind these in vitro pre-
ferences are perhaps reproduced in a diﬀerent way by the
chromatin architecture of post-replicative catenanes
in vivo. Another dissimilarity between in vitro and in vivo
conﬁgurations is that intracellular catenane links might
produce very tight DNA juxtapositions when chromo-
some condensation and segregation forces pull apart repli-
cated DNA molecules. In that case, their conﬁguration
likely facilitates its removal by topoisomerase II.
In the case of DNA relaxation, yeast topoisomerase II
does not have signiﬁcant preference to invert positive or
negative crossings in supercoiled DNA in vitro (91),
though this is not the case in relaxed DNA (95). Inside
the cell, the enzyme must remove also positive and nega-
tive supercoils with comparable eﬃciency. Otherwise,
DNA supercoils of a particular sign would accumulate
in yeast mutants deﬁcient in topoisomerase I (96). This
situation might be slightly diﬀerent in mammalian cells,
since topoisomerase IIa appears to relax in vitro positive
supercoils faster than negative ones, while IIb displays
no such preference (29). To the question of how helical
tension conﬁgures DNA juxtapositions in vivo, one can
assume that DNA is not adopting the same plectoneme
folds seen in naked DNA. The nucleosome structure has
its intrinsic mode of constraining and adapting to DNA
helical stress. Yet, topoisomerase II is found to relax pos-
itive helical tension in native nucleosome arrays nearly at
the same rate as in naked DNA (25). Without displace-
ment of the histones, DNA juxtaposition appears to be
optimized for topoisomerase II activity. In that regard,
recent studies indicated that positive helical tension
drives a chiral transition of nucleosomes to a meta-
stable conformation (reversome) in which H2A–H2B
dimers and the H3–H4 tetramer refold to shape a right-
handed path for DNA (97). Interestingly, the entry and
exit DNA segments of the reversome might conﬁgure a
positive DNA crossing, which could be inverted by topo-
isomerase II. Strand passage would readily revert the
chiral transition of the nucleosome while relaxing the
DNA (Figure 4A).
The second type of DNA juxtaposition is that enforced
by the molecular crowding of intracellular DNA.
Computer simulations of DNA chains under tough con-
densation or volume conﬁnement predict that the duplex
conﬁguration would equilibrate with many knot and cate-
nane links (98–100). Such equilibrium would be achieved
upon random transport of DNA segments, but this
extreme is unlikely to occur. First, chromatin architecture
726 Nucleic Acids Research, 2009, Vol. 37,No. 3might prevent random DNA juxtapositions leading to
undesired knots and catenane links. Second, topoisom-
erase II might keep random knot and catenate links
below the equilibrium values, as it does with DNA in
free solution. Third, undesired links provoked by molecu-
lar crowding will be cleared at the time of chromosome
replication and segregation. The fact is, however, than the
extent of knots and catenanes driven by molecular crowd-
ing of intracellular DNA is unknown. Circular mini-
chromosomes (<10kb) extracted from yeast cells show
negligible catenation and knotting probability (101), but
these ﬁgures could become signiﬁcant in larger chromatin
domains. In such a case, the question is whether such links
might have some biological relevance. For example,
knotting of DNA driven by the molecular crowding
could contribute to stabilize chromosome condensation.
The third type of DNA juxtaposition is that enforced
by the architecture of DNA–protein interactions.
Juxtaposition of nearby intra-molecular DNA segments
is common in eukaryotic chromatin. Wrapping of DNA
around histones brings linker DNA segments in close
proximity; and many other DNA-interacting proteins
bring together nearby DNA regions by looping or kinking
the duplex. The question here is what portion of such
juxtapositions not driven by the topology state of
DNA can be eﬀective pairs of G- and T-segments. It
is conceivable that a juxtaposition is speciﬁcally tailored
to promote DNA transport by topoisomerase II, so creat-
ing a situation analogous to that of DNA gyrase. The
only diﬀerence would be that protein–DNA interactions
enforcing the juxtaposition of a T-segment to conﬁgure
a positive (or negative) crossing would be established
outside rather than inside the topoisomerase-DNA com-
plex (Figure 4B). DNA transport could result then in
supercoiling energy that, unless constrained by other
interactions, could drive critical structural changes in
chromatin micro-domains. Such supercoiling activity
could be behind the implication of topoisomerase II in
local chromatin condensation-decondensation and gene
regulation.
CONCLUSION
In view of our substantial knowledge on topoisomerase II
structure and mechanism, as inferred from in vitro studies,
many questions need to be now addressed pertaining to
how the enzyme performs inside the cell. To the question
of how dimer stability is ensured during the DNA gating
step, one answer is the double-lock rule that allows any of
its three gates to open only if the other two are closed. An
additional answer is a checkpoint to unlock the DNA-
gate, which might allow topoisomerase II to discern
whether a duplex is suitable for rejoining before gating
it. To the question of what prevents ATP hydrolysis,
DNA cleavage or DNA transport by topoisomerase II
when those are not necessary, gate padlocks could be
the answer. Gate padlocks might also operate the transi-
tion from the catalytic to the putative structural functions
of the enzyme. Finally, to the question of what directs
DNA transport probability in the chromatin milieu,
three kinds of DNA juxtaposition can conﬁgure potential
pairs of G- and T-segments to be inverted by intracellular
topoisomerase II: those enforced by DNA topology con-
ﬁguration, those resulting from molecular crowding,
and those customized by chromatin architecture. DNA
transport produces a diﬀerent outcome in each case, so
accounting for the multiple biological roles reserved for
topoisomerase II. More questions will arise, and the initial
answers will be imperfect or quite speculative, as some in
this survey. Yet, this exercise is essential to design crucial
experiments en route for new discoveries.
Figure 4. Juxtaposition of DNA segments enforced by chromatin architecture. (A) Nucleosomes accommodate to positive helical tension (+) by
adopting a meta-stable conformation in which H2A–H2B dimers and the H3–H4 tetramer reorganize and shape a right-handed path for DNA. The
entry and exit DNA segments of this nucleosomal conformation might conﬁgure an ideal positive DNA crossing to be targeted by topoisomerase II.
DNA transport would relax the helical tension and revert the chiral transition of the nucleosome. This scenery might explain why topoisomerase II
relaxes helical tension in nucleosome arrays as eﬃciently as in naked DNA. (B) In absence of DNA helical tension, DNA juxtaposition could be
tailored by neighbouring DNA–protein interactions. DNA transport would then result in supercoiling (or knotting). The reaction would be anal-
ogous to that of DNA gyrase. The only diﬀerence is that protein–DNA interactions enforcing the juxtaposition of a T-segment are established
outside rather than inside the topoisomerase–DNA complex.
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